These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9323083)

  • 1. Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia.
    Mathew V; Cannan CR; Miller VM; Barber DA; Hasdai D; Schwartz RS; Holmes DR; Lerman A
    Circulation; 1997 Sep; 96(6):1930-6. PubMed ID: 9323083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased coronary effects of stimulation of endothelin-B receptor in experimental hypercholesterolemia.
    Mathew V; Miller VM; Hasdai D; Barber DA; Holmes DR; Lerman A
    Coron Artery Dis; 2000 Dec; 11(8):585-92. PubMed ID: 11107505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin at pathophysiological concentrations mediates coronary vasoconstriction via the endothelin-A receptor.
    Cannan CR; Burnett JC; Brandt RR; Lerman A
    Circulation; 1995 Dec; 92(11):3312-7. PubMed ID: 7586319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia.
    Wilson SH; Best PJ; Lerman LO; Holmes DR; Richardson DM; Lerman A
    Cardiovasc Res; 1999 Dec; 44(3):601-7. PubMed ID: 10690293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute endothelin-receptor inhibition does not attenuate acetylcholine-induced coronary vasoconstriction in experimental hypercholesterolemia.
    Hasdai D; Best PJ; Cannan CR; Mathew V; Schwartz RS; Holmes DR; Lerman A
    Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):108-13. PubMed ID: 9445263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced endothelin-B-receptor-mediated vasoconstriction of small porcine coronary arteries in diet-induced hypercholesterolemia.
    Hasdai D; Mathew V; Schwartz RS; Smith LA; Holmes DR; Katusic ZS; Lerman A
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2737-43. PubMed ID: 9409250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary endothelial function is preserved with chronic endothelin receptor antagonism in experimental hypercholesterolemia in vitro.
    Best PJ; Lerman LO; Romero JC; Richardson D; Holmes DR; Lerman A
    Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2769-75. PubMed ID: 10559024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients.
    Shiode N; Nakayama K; Morishima N; Yamagata T; Matsuura H; Kajiyama G
    Am Heart J; 1996 Jun; 131(6):1051-7. PubMed ID: 8644581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypercholesterolemia.
    Hasdai D; Nielsen MF; Rizza RA; Holmes DR; Richardson DM; Cohen P; Lerman A
    Hypertension; 1999 Jul; 34(1):89-95. PubMed ID: 10406829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary microvascular dysfunction after long-term diabetes and hypercholesterolemia.
    Sorop O; van den Heuvel M; van Ditzhuijzen NS; de Beer VJ; Heinonen I; van Duin RW; Zhou Z; Koopmans SJ; Merkus D; van der Giessen WJ; Danser AH; Duncker DJ
    Am J Physiol Heart Circ Physiol; 2016 Dec; 311(6):H1339-H1351. PubMed ID: 27591223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered effects of potassium channel modulation in the coronary circulation in experimental hypercholesterolemia.
    Mathew V; Lerman A
    Atherosclerosis; 2001 Feb; 154(2):329-35. PubMed ID: 11166765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary vascular nitric oxide activity in hypertension and hypercholesterolemia. Comparison of acetylcholine and substance P.
    Quyyumi AA; Mulcahy D; Andrews NP; Husain S; Panza JA; Cannon RO
    Circulation; 1997 Jan; 95(1):104-10. PubMed ID: 8994424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of inhibition of nitric oxide synthesis on epicardial coronary artery caliber and coronary blood flow in humans.
    Lefroy DC; Crake T; Uren NG; Davies GJ; Maseri A
    Circulation; 1993 Jul; 88(1):43-54. PubMed ID: 8319355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of endothelin-1 coronary vasoconstriction in spontaneously hypertensive rats by the nitric oxide system.
    Miki S; Takeda K; Kiyama M; Hatta T; Moriguchi J; Kawa T; Morimoto S; Nakamura K; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):83-7. PubMed ID: 10678275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs.
    Chu A; Chambers DE; Lin CC; Kuehl WD; Palmer RM; Moncada S; Cobb FR
    J Clin Invest; 1991 Jun; 87(6):1964-8. PubMed ID: 2040689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs.
    Lerman A; Webster MW; Chesebro JH; Edwards WD; Wei CM; Fuster V; Burnett JC
    Circulation; 1993 Dec; 88(6):2923-8. PubMed ID: 8252706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries.
    Dubois-Randé JL; Zelinsky R; Roudot F; Chabrier PE; Castaigne A; Geschwind H; Adnot S
    Am J Cardiol; 1992 Nov; 70(15):1269-75. PubMed ID: 1442577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia.
    Taner CB; Severson SR; Best PJ; Lerman A; Miller VM
    J Appl Physiol (1985); 2001 Mar; 90(3):816-20. PubMed ID: 11181588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine acutely modifies nitric oxide synthase function in the human coronary circulation.
    Miner SE; Al-Hesayen A; Nield LE; Gori T; Parker JD
    Exp Physiol; 2010 Dec; 95(12):1167-76. PubMed ID: 20817701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of nitric oxide in bradykinin-induced dilation of coronary resistance vessels in patients with hypercholesterolemia.
    Kato M; Shiode N; Teragawa H; Hirao H; Yamada T; Yamagata T; Matsuura H; Kajiyama G
    Intern Med; 1999 May; 38(5):394-400. PubMed ID: 10397075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.